(Q51771325)

English

Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris.

scientific article published on 12 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pemphigus vulgaris

object named as

pemphigus vulgaris

1 reference

based on heuristic

inferred from title

6

object named as

Rüdiger Eming

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

author name string

Angela Nagel

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Eva Podstawa

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Markus Eickmann

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Hans-Helge Müller

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Michael Hertl

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

language of work or name

0 references

publication date

12 March 2009

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Journal of Investigative Dermatology

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

129

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

2202-2210

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

9

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

https://scigraph.springernature.com/pub.10.1038/jid.2009.27

0 references

Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmunity against desmosomal cadherins in pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF, APRIL and their receptors: structure, function and signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

B cells move to centre stage: novel opportunities for autoimmune disease treatment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

An APRIL to remember: novel TNF ligands as therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

B-cell targeting: a novel approach to immune intervention today and tomorrow

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoadsorption in pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab exerts a dual effect in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

A single cycle of rituximab for the treatment of severe pemphigus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the BAFF/APRIL system on T cell function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of serum antibody levels

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BCMA is essential for the survival of long-lived bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Desmosomes and disease: pemphigus and bullous impetigo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Competence and competition: the challenge of becoming a long-lived plasma cell

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of APRIL and BAFF in lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF and the regulation of B cell survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.27

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JID.2009.27

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/19282839

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51771325&oldid=1778539371"